Old Web
English
Sign In
Acemap
>
Paper
>
PCN131 COST-EFFECTIVENESS ANALYSIS OF AZACITIDINE VS. DECITABINE IN THE TREATMENT OF MYLODYSPLASTIC SYNDROMES IN CHINA
PCN131 COST-EFFECTIVENESS ANALYSIS OF AZACITIDINE VS. DECITABINE IN THE TREATMENT OF MYLODYSPLASTIC SYNDROMES IN CHINA
2020
M. M. Zhao
B. B. Chen
R. Wu
C.S. Fan
Keywords:
Cost-effectiveness analysis
Intensive care medicine
Azacitidine
Medicine
Decitabine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]